| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/16/1999 | CA2421364A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421345A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421333A1 Pro 351 polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421329A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421322A1 Pro703 polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421319A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421315A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421286A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421278A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2421272A1 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | CA2323787A1 Humanized antibody and uses thereof |
| 09/16/1999 | CA2323076A1 Chondrosarcoma associated genes |
| 09/16/1999 | CA2323070A1 Chitinase chitin-binding fragments |
| 09/16/1999 | CA2322771A1 Human membrane spanning proteins |
| 09/16/1999 | CA2322728A1 31 human secreted proteins |
| 09/16/1999 | CA2322662A1 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 09/16/1999 | CA2322508A1 Modified factor viii |
| 09/16/1999 | CA2321026A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/15/1999 | EP0941369A2 Dna for evaluating the progression potential of cervical lesions |
| 09/15/1999 | EP0941368A2 Method for detection of metastatic prostate cancer |
| 09/15/1999 | EP0941349A1 Methods for producing polypeptides in surfactin mutants of bacillus cells |
| 09/15/1999 | EP0941347A2 Methods of producing a recombinant protein |
| 09/15/1999 | EP0941346A1 Secretory immunoglobulin a as a mucosal vaccine delivery system |
| 09/15/1999 | EP0941345A2 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
| 09/15/1999 | EP0941344A1 HUMANIZED ANTI-CD11a ANTIBODIES |
| 09/15/1999 | EP0941341A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 09/15/1999 | EP0941337A1 Synthesis and purification of hepatitis c virus-like particles |
| 09/15/1999 | EP0941335A2 Streptococcus pneumoniae polynucleotides and sequences |
| 09/15/1999 | EP0941334A2 Protease-activatable pseudomonas exotoxin a-like proproteins |
| 09/15/1999 | EP0941332A2 Carrot antifreeze polypeptides |
| 09/15/1999 | EP0941330A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 09/15/1999 | EP0941328A1 Human breast tumor-specific proteins |
| 09/15/1999 | EP0941327A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
| 09/15/1999 | EP0941323A1 Bone morphogenetic protein-16 (bmp-16) compositions |
| 09/15/1999 | EP0941321A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists |
| 09/15/1999 | EP0941315A1 Immune responses using compositions containing stress proteins |
| 09/15/1999 | EP0941311A2 Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates |
| 09/15/1999 | EP0941252A1 Anti-p53 single-chain antibody fragments and their uses |
| 09/15/1999 | EP0941250A1 HUMAN BLUE-LIGHT PHOTORECEPTOR hCRY2 |
| 09/15/1999 | EP0941248A1 Platelet secretory transport protein |
| 09/15/1999 | EP0941244A2 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a method of detecting auto-immune antibodies |
| 09/15/1999 | EP0941239A1 Vertebrate homologues of unc-53 protein of c. elegans |
| 09/15/1999 | EP0941237A1 Cyclic hexapeptides having antibiotic activity |
| 09/15/1999 | EP0851874B1 Novel variants of green fluorescent protein, gfp |
| 09/15/1999 | EP0832098A4 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
| 09/15/1999 | EP0586657B1 Receptor for the glucagon-like-peptide-1 (glp-1) |
| 09/15/1999 | EP0585215B1 Mutants or variants of bacillus thuringiensis producing high yields of delta endotoxin |
| 09/15/1999 | EP0567470B1 Pseudomonas peptide composition and method for producing the same |
| 09/15/1999 | CN1228811A Modulators of BRCAI activity |
| 09/14/1999 | US5952488 A nucleic acid molecule containing an androgen response element linked to a reporter gene; diagnosis and therapy for prostatic diseases and cancer |
| 09/14/1999 | US5952483 Human IκB-β |
| 09/14/1999 | US5952472 Anti-fibroblast growth factor-8 monoclonal antibody |
| 09/14/1999 | US5952469 Murine UCP3 polypeptides |
| 09/14/1999 | US5952468 Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof |
| 09/14/1999 | US5952463 Amino acid sequence of a protein which inhibits enzymes from kex2 family; development of new medicines and pesticides |
| 09/14/1999 | US5952461 Process for preparing human proinsulin |
| 09/14/1999 | US5952212 Anticarcinogenic agents and antidiabetic agents |
| 09/14/1999 | US5952211 Method for producing active human alanine aminotransferase |
| 09/14/1999 | US5952198 Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition |
| 09/14/1999 | US5952195 A nucleic acid fragment having transcriptional promoter activity; for the production of commerical or therapeutic polypeptides of interest in biotechnology |
| 09/14/1999 | US5952187 Antiepileptic agent analog derivatized at the sulfamate moiety or the 9-carbon methyl group to add label for use in immunoassays or to add carrier for use as immunogen; for monitoring serum or plasma levels of drug |
| 09/14/1999 | US5952181 Hybridizing polynucleotide sequence to complementary polynucleotide forming a complex, detecting complex formation; anticarcinogenic agent, treatment of psychological disorders, alzheimer's disease |
| 09/14/1999 | US5952175 DNA encoding a human progesterone receptor complex p23-like protein |
| 09/14/1999 | US5952034 Increasing the digestibility of food proteins by thioredoxin reduction |
| 09/14/1999 | US5952020 Adding microorganisms to aerobically convert cellulose to carbohydrates and convert carbohydrates to proteins; adding cultures to anaerobically convert cellulose to carbohydrates and an organic acid preservative; digestible fodder |
| 09/14/1999 | US5952002 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 09/14/1999 | US5951985 Tumor associated epitope |
| 09/14/1999 | US5951982 Administering an antibody thaat binds an epitope of vcd44; antitumor,-metastasis and carciogenic agents |
| 09/14/1999 | US5951976 Vaccinating a mammal by administering a composition comprising an opsonin-enhanced cell comprising said selected antigen with the provision the opsonin does not bind to a receptor for a fragment of c33 |
| 09/14/1999 | CA2012732C Production of modified pe40 |
| 09/14/1999 | CA1340746C Cloning and expression vectors in an actinomycete strain; process for modifying said strain; actinomycete strain thus obtained and process for preparing proteins |
| 09/14/1999 | CA1340733C Regulatory region for heterologous gene expression in yeast |
| 09/14/1999 | CA1340732C Sv40 expression vector containing hbxag as an expression marker |
| 09/10/1999 | WO1999045132A1 Poly zinc finger proteins with improved linkers |
| 09/10/1999 | WO1999045130A1 Baculovirus expression system and method for high throughput expression of genetic material |
| 09/10/1999 | WO1999045119A2 Production of mycobacterial polypeptides by lactic acid bacteria |
| 09/10/1999 | WO1999045115A1 Human synapse related glycoproteins (hsrp) |
| 09/10/1999 | WO1999045112A2 Chromosome 11-linked coronary heart disease susceptibility gene chd1 |
| 09/10/1999 | WO1999045110A1 V-like domain binding molecules |
| 09/10/1999 | WO1999045108A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 09/10/1999 | WO1999045107A1 Novel calpain and dna encoding the same |
| 09/10/1999 | WO1999045031A2 Cd147 binding molecules as therapeutics |
| 09/10/1999 | WO1999045019A1 Isolated nucleic acid molecules which encode tage molecules, and uses thereof |
| 09/10/1999 | WO1999044626A1 Suppressors of death domains |
| 09/10/1999 | WO1999044620A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/10/1999 | WO1999035263A3 Il-17rh dna and polypeptides |
| 09/10/1999 | WO1999032644A3 Prostate cancer gene |
| 09/10/1999 | WO1999032617A3 Expression cloning in filamentous fungi |
| 09/10/1999 | WO1999031236A3 EXTENDED cDNAs FOR SECRETED PROTEINS |
| 09/10/1999 | WO1999027958A9 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/10/1999 | WO1999027081A9 Alpha/beta hydrolase-fold enzymes |
| 09/10/1999 | WO1999025829A3 Cdk2 protein and cdk2 protein complexes |
| 09/10/1999 | WO1999024472A8 Glycosylated antibodies and antibody fragments having reactive ketone groups |
| 09/10/1999 | WO1999020756A3 Human toll homologues |
| 09/10/1999 | WO1999020644A9 Secreted proteins and polynucleotides encoding them |
| 09/10/1999 | WO1999013907A9 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 09/10/1999 | WO1999001548A3 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
| 09/10/1999 | CA2322749A1 Cd147 binding molecules as therapeutics |
| 09/10/1999 | CA2322621A1 V-like domain binding molecules |
| 09/10/1999 | CA2322505A1 Production of mycobacterial polypeptides by lactic acid bacteria |